Rectify Pharmaceuticals
Cambridge
About Rectify Pharmaceuticals
Rectify is developing disease-modifying precision therapies that restore ABC transporter function to address the underlying cause of serious genetic diseases. The company’s pipeline spans multiple therapeutic areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2021)
- Website: rectifypharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rectify-pharmaceuticals-97296 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.